Home » Topics » BioWorld Science

BioWorld Science
RSS

Shire & Janssen acquire rights to Nivalin

June 4, 1997

State University of New York grants license to Noven for anticavity compounds

June 4, 1997

Shaman issued U.S. patents for type II diabetes compounds

June 4, 1997

Preclinical and clinical data support use of cerebrocrast as neuroprotectant

June 4, 1997

NEP/ACE/ECE inhibitors described by Wakamoto

June 4, 1997

NeoRx reaches milestone in Biostent development

June 4, 1997

U. of California discloses mammalian EPO-BP

June 4, 1997

Anti E- and P-selectin antibodies from PDL

June 4, 1997

Trega Biosciences and Chiroscience collaborate on cell adhesion inhibitors

June 4, 1997

Scios licenses BNP technology to Abbott

June 4, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
How to Summit up? Dis-Harmoni on ivonescimab NSCLC phase III
BioWorld
Wall Street pundits were divided about the likely fate of ivonescimab, Summit Therapeutics Inc.’s bispecific antibody partnered with Akeso Pharmaceuticals Inc.,...